Matches in Nanopublications for { ?s ?p "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.
- NP762008.RAavBvsfGQBQi8C8dz7c-dgu2lIo31YMZ0jq8EUmcTx64130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762008.RAavBvsfGQBQi8C8dz7c-dgu2lIo31YMZ0jq8EUmcTx64130_provenance.
- NP663994.RAJNqovBcgPSdE6yKRLFdL701LKd5dgUAahSjLOrXzfec130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663994.RAJNqovBcgPSdE6yKRLFdL701LKd5dgUAahSjLOrXzfec130_provenance.
- assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP761780.RAnyENf0uvYVOF3dP3Ltr34AqmtfqBFCKn2AFi7iVLq1s130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761780.RAnyENf0uvYVOF3dP3Ltr34AqmtfqBFCKn2AFi7iVLq1s130_provenance.
- NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614022.RAM9d9sC-q5wLceDuUOvkMJeB1DuRYsjWl5IOTphEBOaw130_provenance.
- NP614021.RA9dsYHrDQd_P5ctCC9km2ahmhyg5UQE_k7l5IsZd8hL4130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614021.RA9dsYHrDQd_P5ctCC9km2ahmhyg5UQE_k7l5IsZd8hL4130_provenance.
- NP614023.RAwaifiiqUDVTgnoqXtW5RIF_Tu3QK3cduwE-I-HyTsXA130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614023.RAwaifiiqUDVTgnoqXtW5RIF_Tu3QK3cduwE-I-HyTsXA130_provenance.